%0 Journal Article
%T Intrauterine Thoracoamniotic Shunting of Fetal Hydrothorax with the Somatex Intrauterine Shunt: Intrauterine Course and Postnatal Outcome.
%A Grandt J
%A Gottschalk I
%A Geipel A
%A Gembruch U
%A Simonini C
%A Weber E
%A Berg C
%A Müller A
%A Strizek B
%A Grandt J
%A Gottschalk I
%A Geipel A
%A Gembruch U
%A Simonini C
%A Weber E
%A Berg C
%A Müller A
%A Strizek B
%A Grandt J
%A Gottschalk I
%A Geipel A
%A Gembruch U
%A Simonini C
%A Weber E
%A Berg C
%A Müller A
%A Strizek B
%J J Clin Med
%V 11
%N 9
%D Apr 2022 21
%M 35566436
%F 4.964
%R 10.3390/jcm11092312
%X (1) Background: Severe fetal hydrothorax can be treated by intrauterine thoracoamniotic shunting (TAS). The aim of this study was to assess perinatal outcome and complication rates of TAS with a novel Somatex intrauterine shunt. (2) Methods: This is a single-center retrospective study of all fetuses with hydrothorax treated with TAS using a Somatex shunt between 2014 and 2020. (3) Results: A total of 39 fetuses were included in the study. Mean gestational age at first intervention was 27.4 weeks (range 19-33). Of these, 51% (n = 20) of fetuses had fetal hydrops, which resolved in 65% (13/20) before delivery. The live birth rate was 97% (n = 38), and 74% (n = 29) survived the neonatal period. The rate of postnatal pulmonary complications was high, with 88% of neonates requiring any kind of ventilatory support. There were 23% (n = 9) genetic abnormalities (trisomy 21 and Noonan syndrome). (4) Conclusions: TAS with a Somatex shunt has a high technical success rate, leading to high neonatal survival rates. Pregnancy and neonatal outcome is comparable to TAS for fetal hydrothorax using different shunt types.